脊柱外科杂志
脊柱外科雜誌
척주외과잡지
JOURNAL OF SPINE SURGERY
2014年
6期
375-379
,共5页
邬均%胡运玖%左奕%李吉东%李玉宝%蒋电明
鄔均%鬍運玖%左奕%李吉東%李玉寶%蔣電明
오균%호운구%좌혁%리길동%리옥보%장전명
结核,脊柱%微球体%羟基乳酸聚合物910%利福霉素类%缓效制剂
結覈,脊柱%微毬體%羥基乳痠聚閤物910%利福黴素類%緩效製劑
결핵,척주%미구체%간기유산취합물910%리복매소류%완효제제
Tuberculosis,spinal%Microspheres%Polyglactin 910%Rifamycins%Delayed-action preparations
目的:制备可用于持续抑制脊柱结核术后病灶残留结核分枝杆菌的载利福喷丁/聚乳酸-聚乙醇酸共聚物[ Poly( lactic-co-glycolic acid), PLGA]微球,并研究其体外释放性能。方法通过乳化-溶剂挥发法制备载利福喷丁/PLGA微球,光学显微镜和扫描电镜观察微球形貌,激光粒度分布仪测定微球粒径及分布,紫外分光光度计测定微球载药量及包封率。检测利福喷丁抗结核分枝杆菌的最低抑菌浓度,并以pH=7.4的PBS缓冲溶液为释放介质,紫外分光光度计检测载药微球体外释放特性。结果载利福喷丁/PLGA微球成球形状良好,表面光滑,分散性好,粒径分布均匀,平均粒径为25.49μm。载药量及包封率分别为21.37%±0.16%和74.79%±2.71%。体外释放实验显示在突释期内,利福喷丁释放量占载药微球中药物含量的37.08%±1.68%;在缓释期内载药微球释药速度减慢,第5周释放量仍超过利福喷丁抗结核分枝杆菌的最低抑菌浓度,35 d后体外累积释放量为80.67%±0.97%,仍高于利福喷丁抗结核分枝杆菌的最低抑菌浓度2μg/mL。结论 PLGA是一种理想的控缓释材料,所制备的载利福喷丁/PLGA微球具有良好的控释效果,是一种有效的抗结核缓释剂型。
目的:製備可用于持續抑製脊柱結覈術後病竈殘留結覈分枝桿菌的載利福噴丁/聚乳痠-聚乙醇痠共聚物[ Poly( lactic-co-glycolic acid), PLGA]微毬,併研究其體外釋放性能。方法通過乳化-溶劑揮髮法製備載利福噴丁/PLGA微毬,光學顯微鏡和掃描電鏡觀察微毬形貌,激光粒度分佈儀測定微毬粒徑及分佈,紫外分光光度計測定微毬載藥量及包封率。檢測利福噴丁抗結覈分枝桿菌的最低抑菌濃度,併以pH=7.4的PBS緩遲溶液為釋放介質,紫外分光光度計檢測載藥微毬體外釋放特性。結果載利福噴丁/PLGA微毬成毬形狀良好,錶麵光滑,分散性好,粒徑分佈均勻,平均粒徑為25.49μm。載藥量及包封率分彆為21.37%±0.16%和74.79%±2.71%。體外釋放實驗顯示在突釋期內,利福噴丁釋放量佔載藥微毬中藥物含量的37.08%±1.68%;在緩釋期內載藥微毬釋藥速度減慢,第5週釋放量仍超過利福噴丁抗結覈分枝桿菌的最低抑菌濃度,35 d後體外纍積釋放量為80.67%±0.97%,仍高于利福噴丁抗結覈分枝桿菌的最低抑菌濃度2μg/mL。結論 PLGA是一種理想的控緩釋材料,所製備的載利福噴丁/PLGA微毬具有良好的控釋效果,是一種有效的抗結覈緩釋劑型。
목적:제비가용우지속억제척주결핵술후병조잔류결핵분지간균적재리복분정/취유산-취을순산공취물[ Poly( lactic-co-glycolic acid), PLGA]미구,병연구기체외석방성능。방법통과유화-용제휘발법제비재리복분정/PLGA미구,광학현미경화소묘전경관찰미구형모,격광립도분포의측정미구립경급분포,자외분광광도계측정미구재약량급포봉솔。검측리복분정항결핵분지간균적최저억균농도,병이pH=7.4적PBS완충용액위석방개질,자외분광광도계검측재약미구체외석방특성。결과재리복분정/PLGA미구성구형상량호,표면광활,분산성호,립경분포균균,평균립경위25.49μm。재약량급포봉솔분별위21.37%±0.16%화74.79%±2.71%。체외석방실험현시재돌석기내,리복분정석방량점재약미구중약물함량적37.08%±1.68%;재완석기내재약미구석약속도감만,제5주석방량잉초과리복분정항결핵분지간균적최저억균농도,35 d후체외루적석방량위80.67%±0.97%,잉고우리복분정항결핵분지간균적최저억균농도2μg/mL。결론 PLGA시일충이상적공완석재료,소제비적재리복분정/PLGA미구구유량호적공석효과,시일충유효적항결핵완석제형。
Objective To prepare Poly( lactic-co-glycolic acid) ( PLGA) microspheres loaded with rifapentine to sustain-ably sterilize in the lesions of spinal tuberculosis.The physicochemical characteristics and in vitro release characteristics of rifapentine-loaded PLGA microspheres was studied in details.Methods Rifapentine-loaded PLGA microspheres was pre-pared by using single-emulsion solvent evaporation ( water-in-oil, O/W ) method, their morphology was observed by light microscope and scanning electron microscopy (SEM).Rifapentine-loaded PLGA microspheres were analyzed about diameter with laser particle size analyzer, and their drug-loading rate and encapsulation rate were determined by ultraviolet spectropho-tometry.The minimal inhibitory concentration (MIC) of rifapentine against mycobacterium tuberculosis (H37Rv) was meas-ured.The microspheres were enclosed in the dialysis bag which suspended in PBS buffer solution (0.2 mol/L, pH7.4), the release amount of rifapentine was detected by ultraviolet spectrophotometry and release curve was mapped.Results Rifapen-tine/PLGA microspheres presented sphericity, smooth surface, good dispersibility and uniform particle size.Their average particle size was 25.49 μm, the drug-loading rate and encapsulation rate was 21.37%±0.16% and 74.79%±2.71%, respectively.Almost 37.08%±1.68% of the rifampicin contained in the microspheres were released into PBS in the first 12 h.Although gradually reduced, the drug release in the fifth week was much higher than MIC, and rose to 80.67%± 0.97%35 d later, at that time the inhibitory concentration was more than the MIC of rifapentine against H37Rv 2 μg/mL. Conclusion PLGA is an ideal material for sustained-release preparations, and the rifapentine/PLGA microsphere was an effective antituberculosis dosage form, for its characteristics of well controlled-release effects.